Evidence map›Paper›PMID 34094948›Full record

ArticleFrontiers in oncology2021

XBP1- IGFBP3 Signaling Pathway Promotes NSCLC Invasion and Metastasis.

Qingxi Luo, Wenwen Shi, Bo Dou, Jun Wang, Wei Peng, Xianyu Liu, Deze Zhao, Faqing Tang, Yingfang Wu, Xizhe Li and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Endoplasmic reticulum stress in non-small cell lung cancer.American journal of cancer research · 2025
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Molecular Mechanism Underlying Role of the XBP1s in Cardiovascular Diseases.Journal of cardiovascular development and disease · 2022
    Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Qingxi LuoDepartment of Thoracic Surgery, Xiangya Hospital, Central South University, Changsha, China.
Wenwen ShiDepartment of Thoracic Surgery, Xiangya Hospital, Central South University, Changsha, China.
Bo DouDepartment of Thoracic Surgery, Xiangya Hospital, Central South University, Changsha, China.
Jun WangDepartment of Thoracic Surgery, Xiangya Hospital, Central South University, Changsha, China.
Wei PengDepartment of Oncology, Hunan Provincial People's Hospital/The First Affiliated Hospital of Hunan Normal University, Changsha, China.
Xianyu LiuDepartment of Thoracic Surgery, Xiangya Hospital, Central South University, Changsha, China.
Deze ZhaoDepartment of Thoracic Surgery, Xiangya Hospital, Central South University, Changsha, China.
Faqing TangHunan Key Laboratory of Oncotarget Gene, Department of Clinical Laboratory, Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Yingfang WuCentre of Stomatology, Xiangya Hospital, Central South University, Changsha, China.
Xizhe LiDepartment of Thoracic Surgery, Xiangya Hospital, Central South University, Changsha, China.
Jiajia LiDepartment of Thoracic Surgery, Xiangya Hospital, Central South University, Changsha, China.
Siqi WenDepartment of Thoracic Surgery, Xiangya Hospital, Central South University, Changsha, China.
Chunfang ZhangDepartment of Thoracic Surgery, Xiangya Hospital, Central South University, Changsha, China.
Chaojun DuanDepartment of Thoracic Surgery, Xiangya Hospital, Central South University, Changsha, China.
Xiangya Hospital Central South University · CNCentral South University · CNHunan Cancer Hospital · CNHunan Provincial People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer is the most frequently diagnosed cancer and the main cause of cancer death in the world. X-box binding protein 1 (XBP1), which is an important transcription factor involved in regulating the unfolded protein response (UPR) during endoplasmic reticulum (ER) stress, might act as a potent oncogenic protein in the processes of tumorigenesis, tumor proliferation and metastasis in various cancers. However, the clinical significance and pathological role of XBP1 in non-small cell lung cancer (NSCLC) remains unknown. In this study, we investigated the expression of XBP1s protein in the 104 NSCLC tumor tissues and matched adjacent normal lung tissues (ANLT) by Immunohistochemical (IHC), and we found overexpressed XBP1s protein was associated with NSCLC TNM stages, lymph node metastasis and poor prognosis. The further gain-and loss-of-function experiments indicated overexpression of XBP1s protein promoted cell invasion, migration and metastasis both

Indexed as

IGFBP3invasionmetastasisNSCLCXBP1

Identifiers

PMID34094948
PMCPMC8169999
OpenAlexW3161230181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.